Craig A. Barbarosh

Craig A. Barbarosh sits as a Director at five companies: Sabra Health Care REIT, Inc. (70 filings), Nextgen Healthcare, Inc. (19), Evolent Health, Inc. (8), Lifecore Biomedical, Inc. (7) and Bazaarvoice Inc (3), for 109 filings published from January 4, 2016 to June 18, 2026.

Almost everything is equity pay: 92 grants, 2 option exercises and 4 filings of another nature. Market trades are discreet: 10 sales worth EUR 882,139 in total with a median of EUR 65,262, all at Nextgen Healthcare in 2021. The three largest are from April 12 (EUR 141,254), November 2 (EUR 128,337) and August 3 (EUR 122,351). A single purchase, EUR 16,322 at Evolent Health on March 6, 2025, makes up 9% of market trades.

Yearly volume is stable: 7 to 13 filings a year, with 13 in both 2021 and 2022. Five filings fall in the last twelve months, with no market trade. The median publication delay is 3 days.

At Nextgen Healthcare, 3 of Barbarosh's trades coincide within 30 days with those of David A. Metcalfe, 2 with those of Mitchell Waters and 1 with those of David Ahmadzai, in the same direction.